Litcius/Paper detail

Ocrelizumab B-cell repopulation-guided extended interval dosing versus standard dosing – similar clinical efficacy with decreased immunoglobulin M deficiency rates

Torge Rempe, Aisha Elfasi, Elsa Rodriguez, Matthew Vasquez, Jennifer Graves, Revere P. Kinkel

2023Multiple Sclerosis and Related Disorders25 citationsDOI

Topics & Concepts

MedicineDosingRegimenInternal medicineGastroenterologyAntibodyRepopulationImmunologyBiologyGeneticsStem cellHaematopoiesisMultiple Sclerosis Research StudiesMonoclonal and Polyclonal Antibodies ResearchMultiple Myeloma Research and Treatments
Ocrelizumab B-cell repopulation-guided extended interval dosing versus standard dosing – similar clinical efficacy with decreased immunoglobulin M deficiency rates | Litcius